AGLIETTA, Massimo
AGLIETTA, Massimo
ONCOLOGIA
153Samarium-EDTMP administration followed by hematopoietic stem cell support for bone metastases in osteosarcoma patients.
2012-01-01 Berger M; Grignani G; Giostra A; Ferrari S; Ferraresi V; Tamburini A; Cefalo G; Carnevale-Schianca F; Vassallo E; Picci P; Pagano M; Aglietta M; Pellerito RE; Fagioli F.
28th meeting of the Italian Cancer Society (SIC). New challenges of molecular oncology.
2002-01-01 LOLLINI PL; PIEROTTI MA; PASSERINI CG; BANI MR; ZUPI G; AGLIETTA M; ALBINI A
45th annual meeting of the Italian Cancer Society. Bergamo, 9-12 November 2003
2004-01-01 GIAVAZZI R; AGLIETTA M; ASTOLFI A; FALANGA A; FUSCO A; LABIANCA R; LOLLINI PL; LOMBARDO C; NATALI PG; PIEROTTI MA; PRESTA M; SANTORO M; TARABOLETTI G; ZUPI G; VECCHIO G
[Diagnosis of neoplastic ascites: combined use of albumin gradient between serum and ascites and cholesterol in ascitic fluid]
1996-01-01 SARTORI M ;ANDORNO S ;BERMANI G ;COLOMBI S ;GAMBARO M ;LA TERRA G ;LEONE F ;MOLINARI GL ;AGLIETTA M
[Diagnostic approach to the anemic cancer patient]
1997-01-01 AGLIETTA M
[GM-CSF: target cells and their response kinetics]
1989-01-01 M. Aglietta; W. Piacibello; Aprá F; Stacchini A; Sanavio F; Monzeglio C;Mossetti C; F. Bussolino; Gavosto G.
[Lethal midline granuloma (LMG). Review of the literature and report of a case]
1990-01-01 BOCCA M ;AGLIETTA M ;PUGLISI A ;POMATTO E ;GHIGGIA M
[Prevalence of anemia in oncologic patients treated with chemotherapy. Italian survey at the national level]
2001-01-01 BERNARDO G ;AGLIETTA M ;AMADORI D ;BECCAGLIA P ;BELLI G ;BIANCO R ;CIONINI L ;COGNETTI F ;COLUCCI G ;COMELLA G ;DI COSTANZO F ;MARCHETTI P ;PRONZATO P
[Prevention and treatment of febrile neutropenia]
1997-01-01 MONTEMURRO F ;GALLICCHIO M ;AGLIETTA M
[The use of erythropoietin alpha in programs of high-dose chemotherapy]
2000-01-01 DANOVA M ;AGLIETTA M ;PIERELLI L ;FERRARI S ;PERILLO A ;SCAMBIA G ;HENRY D
A comparison of allografting with autografting for newly diagnosed myeloma
2007-01-01 BRUNO B; ROTTA M; PATRIARCA F; MORDINI N; ALLIONE B; CARNEVALE-SCHIANCA F; GIACCONE L; SORASIO R; OMEDE P; BALDI I; BRINGHEN S; MASSAIA M; AGLIETTA M; LEVIS A; GALLAMINI A; FANIN R; PALUMBO A; STORB R; CICCONE G; BOCCADORO M
A comparison of two GM-CSF schedules to counteract the granulo-monocytopenia of carboplatin-etoposide chemotherapy.
1995-01-01 TAFUTO S ;ABATE G ;D'ANDREA P ;SILVESTRI I ;MARCOLIN P ;VOLTA C ;MONTEVERDE A ;COLOMBI S ;ANDORNO S ;AGLIETTA M
A large-scale study of bone marrow involvement in patients with Hodgkin's lymphoma
2004-01-01 LEVIS A; PIETRASANTA D; GODIO L; VITOLO U; CIRAVEGNA G; DI VITO F; GAVAROTTI P; GUGLIELMELLI T; ORSUCCI L; RAVIOLO E; SCALABRINI DR; SALVI F;T ONSO A; AGLIETTA M; BOCCADORO M; GALLAMINI A; SAGLIO G; SCASSA E; GALLO E
A modified Trastuzumab antibody for the immunohistochemical detection of HER-2 overexpression in breast cancer
2005-01-01 BUSSOLATI G; MONTEMURRO F; RIGHI L; DONADIO M; AGLIETTA M; SAPINO A
A novel multidrug‐resistant cell line from an italian intrahepatic cholangiocarcinoma patient
2021-01-01 Peraldo-neia C.; Massa A.; Vita F.; Basirico M.; Raggi C.; Bernabei P.; Ostano P.; Casorzo L.; Panero M.; Leone F.; Cavalloni G.; Aglietta M.
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index
2021-01-01 Rovesti G.; Leone F.; Brandi G.; Cesario S.; Scartozzi M.; Niger M.; Yoo C.; Filippi R.; Casagrande M.; Silvestris N.; Santini D.; Faloppi L.; Palloni A.; Aglietta M.; Bernardini L.; Cho H.; Lai E.; Fenocchio E.; Pircher C.; Iacono D.; De Lorenzo S.; Sperti E.; Massa V.; De Braud F.; Jeong J.H.; Aprile G.; Burgio V.; Cascinu S.; Casadei-Gardini A.
A phase 2 trial of imatinib mesylate in patients with recurrent nonresectable chondrosarcomas expressing platelet-derived growth factor receptor-α or -β: an Italian Sarcoma Group study.
2011-01-01 Grignani G; Palmerini E; Stacchiotti S; Boglione A; Ferraresi V; Frustaci S; Comandone A; Casali PG; Ferrari S; Aglietta M.
A phase I dose-escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer.
2014-01-01 Aglietta M;Barone C;Sawyer MB;Moore MJ;Miller WH Jr;Bagalà C;Colombi F;Cagnazzo C;Gioeni L;Wang E;Huang B;Fly KD;Leone F
A phase II study of three-weekly docetaxel and weekly trastuzumab in HER2-overexpressing advanced breast cancer
2004-01-01 MONTEMURRO F; CHOA G; FAGGIUOLO R; DONADIO M; MINISCHETTI M; DURANDO A; CAPALDI A; VIETTI-RAMUS G; ALABISO O; AGLIETTA M
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study.
2012-01-01 Grignani G; Palmerini E; Dileo P; Asaftei SD; D'Ambrosio L; Pignochino Y; Mercuri M; Picci P; Fagioli F; Casali PG; Ferrari S; Aglietta M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 153Samarium-EDTMP administration followed by hematopoietic stem cell support for bone metastases in osteosarcoma patients. | 2012 | Berger M; Grignani G; Giostra A; Ferrari S; Ferraresi V; Tamburini A; Cefalo G; Carnevale-Schianca F; Vassallo E; Picci P; Pagano M; Aglietta M; Pellerito RE; Fagioli F. | |
| 28th meeting of the Italian Cancer Society (SIC). New challenges of molecular oncology. | 2002 | LOLLINI PL; PIEROTTI MA; PASSERINI CG; BANI MR; ZUPI G; AGLIETTA M; ALBINI A | |
| 45th annual meeting of the Italian Cancer Society. Bergamo, 9-12 November 2003 | 2004 | GIAVAZZI R; AGLIETTA M; ASTOLFI A; FALANGA A; FUSCO A; LABIANCA R; LOLLINI PL; LOMBARDO C; NATALI PG; PIEROTTI MA; PRESTA M; SANTORO M; TARABOLETTI G; ZUPI G; VECCHIO G | |
| [Diagnosis of neoplastic ascites: combined use of albumin gradient between serum and ascites and cholesterol in ascitic fluid] | 1996 | SARTORI M ;ANDORNO S ;BERMANI G ;COLOMBI S ;GAMBARO M ;LA TERRA G ;LEONE F ;MOLINARI GL ;AGLIETTA M | |
| [Diagnostic approach to the anemic cancer patient] | 1997 | AGLIETTA M | |
| [GM-CSF: target cells and their response kinetics] | 1989 | M. Aglietta; W. Piacibello; Aprá F; Stacchini A; Sanavio F; Monzeglio C;Mossetti C; F. Bussolino; Gavosto G. | |
| [Lethal midline granuloma (LMG). Review of the literature and report of a case] | 1990 | BOCCA M ;AGLIETTA M ;PUGLISI A ;POMATTO E ;GHIGGIA M | |
| [Prevalence of anemia in oncologic patients treated with chemotherapy. Italian survey at the national level] | 2001 | BERNARDO G ;AGLIETTA M ;AMADORI D ;BECCAGLIA P ;BELLI G ;BIANCO R ;CIONINI L ;COGNETTI F ;COLUCCI G ;COMELLA G ;DI COSTANZO F ;MARCHETTI P ;PRONZATO P | |
| [Prevention and treatment of febrile neutropenia] | 1997 | MONTEMURRO F ;GALLICCHIO M ;AGLIETTA M | |
| [The use of erythropoietin alpha in programs of high-dose chemotherapy] | 2000 | DANOVA M ;AGLIETTA M ;PIERELLI L ;FERRARI S ;PERILLO A ;SCAMBIA G ;HENRY D | |
| A comparison of allografting with autografting for newly diagnosed myeloma | 2007 | BRUNO B; ROTTA M; PATRIARCA F; MORDINI N; ALLIONE B; CARNEVALE-SCHIANCA F; GIACCONE L; SORASIO R; OMEDE P; BALDI I; BRINGHEN S; MASSAIA M; AGLIETTA M; LEVIS A; GALLAMINI A; FANIN R; PALUMBO A; STORB R; CICCONE G; BOCCADORO M | |
| A comparison of two GM-CSF schedules to counteract the granulo-monocytopenia of carboplatin-etoposide chemotherapy. | 1995 | TAFUTO S ;ABATE G ;D'ANDREA P ;SILVESTRI I ;MARCOLIN P ;VOLTA C ;MONTEVERDE A ;COLOMBI S ;ANDORNO S ;AGLIETTA M | |
| A large-scale study of bone marrow involvement in patients with Hodgkin's lymphoma | 2004 | LEVIS A; PIETRASANTA D; GODIO L; VITOLO U; CIRAVEGNA G; DI VITO F; GAVAROTTI P; GUGLIELMELLI T; ORSUCCI L; RAVIOLO E; SCALABRINI DR; SALVI F;T ONSO A; AGLIETTA M; BOCCADORO M; GALLAMINI A; SAGLIO G; SCASSA E; GALLO E | |
| A modified Trastuzumab antibody for the immunohistochemical detection of HER-2 overexpression in breast cancer | 2005 | BUSSOLATI G; MONTEMURRO F; RIGHI L; DONADIO M; AGLIETTA M; SAPINO A | |
| A novel multidrug‐resistant cell line from an italian intrahepatic cholangiocarcinoma patient | 2021 | Peraldo-neia C.; Massa A.; Vita F.; Basirico M.; Raggi C.; Bernabei P.; Ostano P.; Casorzo L.; Panero M.; Leone F.; Cavalloni G.; Aglietta M. | |
| A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index | 2021 | Rovesti G.; Leone F.; Brandi G.; Cesario S.; Scartozzi M.; Niger M.; Yoo C.; Filippi R.; Casagrande M.; Silvestris N.; Santini D.; Faloppi L.; Palloni A.; Aglietta M.; Bernardini L.; Cho H.; Lai E.; Fenocchio E.; Pircher C.; Iacono D.; De Lorenzo S.; Sperti E.; Massa V.; De Braud F.; Jeong J.H.; Aprile G.; Burgio V.; Cascinu S.; Casadei-Gardini A. | |
| A phase 2 trial of imatinib mesylate in patients with recurrent nonresectable chondrosarcomas expressing platelet-derived growth factor receptor-α or -β: an Italian Sarcoma Group study. | 2011 | Grignani G; Palmerini E; Stacchiotti S; Boglione A; Ferraresi V; Frustaci S; Comandone A; Casali PG; Ferrari S; Aglietta M. | |
| A phase I dose-escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer. | 2014 | Aglietta M;Barone C;Sawyer MB;Moore MJ;Miller WH Jr;Bagalà C;Colombi F;Cagnazzo C;Gioeni L;Wang E;Huang B;Fly KD;Leone F | |
| A phase II study of three-weekly docetaxel and weekly trastuzumab in HER2-overexpressing advanced breast cancer | 2004 | MONTEMURRO F; CHOA G; FAGGIUOLO R; DONADIO M; MINISCHETTI M; DURANDO A; CAPALDI A; VIETTI-RAMUS G; ALABISO O; AGLIETTA M | |
| A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study. | 2012 | Grignani G; Palmerini E; Dileo P; Asaftei SD; D'Ambrosio L; Pignochino Y; Mercuri M; Picci P; Fagioli F; Casali PG; Ferrari S; Aglietta M. |